アメリカのバイオ技術・遺伝学産業年鑑2016:市場調査、統計、動向、企業分析

◆英語タイトル:Plunkett's Biotech & Genetics Industry Almanac 2016: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
◆商品コード:PLUN605006
◆発行会社(調査会社):Plunkett Research
◆発行日:2015年11月27日
◆ページ数:570
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:米国
◆産業分野:バイオ技術・遺伝学
◆販売価格オプション(消費税別)
Single UserUSD350 ⇒換算¥39,900見積依頼/購入/質問フォーム
Corporate Licence(社内共有可)USD1,995 ⇒換算¥227,430見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はPlunkett Research社の日本における正規販売代理店です。Plunkett Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

PLUNKETT’S BIOTECH & GENETICS INDUSTRY ALMANAC 2016
Key Findings:

-Plunkett Research lists top 400 companies in the Biotech & Genetics and names top trends changing the industry for the mid term.

Key Features:

-Industry trends analysis, market data and competitive intelligence
-Market forecasts and Industry Statistics
-Industry Associations and Professional Societies List
-In-Depth Profiles of hundreds of leading companies
-Industry Glossary
-Buyer may register for free access to search and export data at Plunkett Research Online
-Link to our 5-minute video overview of this industry

Pages: 570
Statistical Tables Provided: 16
Companies Profiled: 399
Geographic Focus: Global

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments.
-How is the industry evolving?
-How is the industry being shaped by new technologies?
-How is demand growing in emerging markets and mature economies?
-What is the size of the market now and in the future?
-What are the financial results of the leading companies?
-What are the names and titles of top executives?
-What are the top companies and what are their revenues?

Contents, Statistics, Forecasts and Analysis Include:
Major Trends Affecting the Biotech & Genetics Industry

1) The State of the Biotechnology Industry Today
2) A Short History of Biotechnology
3) Ethanol Production Soared, But U.S. Federal Subsidy Expires
4) Cellulosic Ethanol Makes Slow Commercial Progress
5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
9) Vaccines and Viruses in Drug Delivery
10) New Blockbuster Drugs Come to Market/ Drug Prices Soar/Generics Offer Some Relief
11) Biotech and Orphan Drugs Create New Revenues for Drug Firms
12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs
14) Stem Cells—Multiple Sources Stem from New Technologies
15) Government Support for Stem Cell Research Evolves
16) Stem Cells—Therapeutic Cloning Techniques Advance
17) Stem Cells—A New Era of Tissue Replacement Takes Shape
18) Nanotechnology Converges with Biotech
19) Genetically Modified (GM) Seeds and Crops/R&D Investment Is High
20) Genetically Modified (GM) Ingredients in Processed or Packaged Foods
21) Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals
22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories
23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs
24) Immunotherapy Promises New Approach to Fighting Cancers
25) Technology Discussion—Genes and DNA
26) Technology Discussion—Proteins and Proteomics
27) Technology Discussion—Microarrays
28) Technology Discussion—DNA Chips
29) Technology Discussion—SNPs (“Snips”)
30) Technology Discussion—Combinatorial Chemistry
31) Technology Discussion—Synthetic Biology
32) Technology Discussion—Recombinant DNA
33) Technology Discussion—Polymerase Chain Reaction (PCR)

Biotech & Genetics Industry Statistics
1) Biotech Industry Overview
2) The U.S. Drug Discovery & Approval Process
3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2014
4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2014
5) Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2014
6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2013-2015
7) U.S. Exports & Imports of Pharmaceutical Products: 2009-1st Quarter 2015
8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2007-2023
9) Prescription Drug Expenditures, U.S.: Selected Years, 1960-2023
10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2014
11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2014-2016
12) Global Area of Biotech Crops by Country: 2014
13) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2014
14) Sales By Geographic Area, PhRMA Member Companies: 2013
15) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2014
16) Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2013

【レポートの目次】

PLUNKETT’S BIOTECH & GENETICS
INDUSTRY ALMANAC 2016
CONTENTS
Introduction 1
How to Use This Book 3
Chapter 1: Major Trends Affecting the Biotech & Genetics Industry 6
1) The State of the Biotechnology Industry Today 7
2) A Short History of Biotechnology 10
3) Ethanol Production Soared, But U.S. Federal Subsidy Expires 12
4) Cellulosic Ethanol Makes Slow Commercial Progress 13
5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms 14
6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech
Development 15
7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance 16
8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing 18
9) Vaccines and Viruses in Drug Delivery 19
10) New Blockbuster Drugs Come to Market/ Drug Prices Soar/Generics Offer Some Relief 20
11) Biotech and Orphan Drugs Create New Revenues for Drug Firms 23
12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated
Approval/Competition Will Be Fierce 23
13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs 24
14) Stem Cells—Multiple Sources Stem from New Technologies 25
15) Government Support for Stem Cell Research Evolves 27
16) Stem Cells—Therapeutic Cloning Techniques Advance 28
17) Stem Cells—A New Era of Tissue Replacement Takes Shape 29
18) Nanotechnology Converges with Biotech 30
19) Genetically Modified (GM) Seeds and Crops/R&D Investment Is High 31
20) Genetically Modified (GM) Ingredients in Processed or Packaged Foods 33
21) Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals 34
22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories 34
23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs 35
24) Immunotherapy Promises New Approach to Fighting Cancers 35
25) Technology Discussion—Genes and DNA 36
26) Technology Discussion—Proteins and Proteomics 37
27) Technology Discussion—Microarrays 37
28) Technology Discussion—DNA Chips 38
29) Technology Discussion—SNPs (“Snips”) 38
30) Technology Discussion—Combinatorial Chemistry 38
31) Technology Discussion—Synthetic Biology 39
32) Technology Discussion—Recombinant DNA 39
33) Technology Discussion—Polymerase Chain Reaction (PCR) 40
Chapter 2: Biotech & Genetics Industry Statistics 41
Biotech Industry Overview 42
The U.S. Drug Discovery & Approval Process 43
U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2014 44
U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME)
Approvals: 1993-2014 45
Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2014 46
Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.:
Fiscal Years 2013-2015 47
U.S. Exports & Imports of Pharmaceutical Products: 2009-1st Quarter 2015 48
U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution:
2007-2023 49
Prescription Drug Expenditures, U.S.: Selected Years, 1960-2023 51
Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2014 52
Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years
2014-2016 53
Global Area of Biotech Crops by Country: 2014 54
Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2014 55
Sales By Geographic Area, PhRMA Member Companies: 2013 56
Domestic U.S. Biopharmaceutical R&D & R&D Abroad,
PhRMA Member Companies: 1980-2014 57
Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown,
PhRMA Member Companies: 2013 58
Chapter 3: Important Biotech & Genetics Industry Contacts 59
(Addresses, Phone Numbers and Internet Sites)
Chapter 4: THE BIOTECH 400:
Who They Are and How They Were Chosen 97
Index of Companies Within Industry Groups 98
Alphabetical Index 107
Index of U.S. Headquarters Location by State 110
Index of Non-U.S. Headquarters Location by Country 113
Individual Profiles on Each of THE BIOTECH 400 116
Additional Indexes
Index of Hot Spots for Advancement for Women/Minorities 517
Index by Subsidiaries, Brand Names and Selected Affiliations 519
A Short Biotech & Genetics Industry Glossary 540



★調査レポート[アメリカのバイオ技術・遺伝学産業年鑑2016:市場調査、統計、動向、企業分析]販売に関する免責事項
★調査レポート[アメリカのバイオ技術・遺伝学産業年鑑2016:市場調査、統計、動向、企業分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆